Abstract
Treating stroke with tissue plasminogen activator (tPA) can help dissolve blood clots and improve outcome. But tPA also increases the risk of hemorrhage and has other deleterious effects. A new approach to treatment minimizes these negative effects.
Original language | English (US) |
---|---|
Pages (from-to) | 993-994 |
Number of pages | 2 |
Journal | Nature medicine |
Volume | 12 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2006 |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)